|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINAL PROGRAMME |
|
|
|
|
Friday 20th May 2005 |
|
|
|
|
|
Name |
Country |
Title |
|
|
|
Chair: ET
Rippmann (Switzerland), A Kurjak (Croatia) |
|
|
|
ET Rippmann |
Switzerland |
The
philosophy of Organization Gestosis |
|
|
A Kurjak |
Croatia |
3D and 4D ultrasound assessment of fetal behavior in
patients with IUGR and EPH gestosis |
|
|
I de Luca Brunori |
Italy |
HLA-R in couples associated with preeclampsia:
background and updating by DNA sequencing |
|
|
Chair: I de Luca Brunori (Italy), I
Damjanov (USA) |
|
|
LE Mourachko |
Russia |
Pathogenesis, treatment and prevention of
gestosis |
|
|
S Skrablin Kucic |
Croatia |
Expectant management of patients with severe
preeclampsia - maternal and perinatal outcome |
|
|
I Damjanov |
USA |
Renal, liver and placental pathologic changes in
preeclampsia. What's new? |
|
|
A Chkheidze |
Georgia |
EPH-gestosis, atypical forms, definition and
nosography |
|
|
Chair: Z Alfirevic (UK), I Kuvacic
(Croatia) |
|
|
Z
Alfirevic |
UK |
Antihypertensive therapy of severe preeclampsia /
eclampsia |
|
|
S Meher |
UK |
Prevention of preeclampsia: evidence from randomized trials and
systematic reviews |
|
|
I Kuvacic |
Croatia |
Preeclampsia. When should we go for termination /
delivery? |
|
|
Chair: S Meher (UK), R
Matijevic (Croatia), O Grgic (Croatia) |
|
|
K Czajkowski, J Sienko, I Kostro et al |
Poland |
Perinatal outcome in pregnancy complicated by chronic
hypertension |
|
|
N Vecek, R Dmitrovic, V
Blagaic ml et al |
Croatia |
Oocyte donation to a 51-year old woman resulting in
HELLP syndrome |
|
|
D
Tutunaru, SI Avram |
Romania |
First trimester serum homocysteine levels: prediction
parameter for preeclampisia |
|
|
DM
Paternoster, S Fantinato, A Memmo et al |
Italy |
Inhibin-A and C-reactive protein in preeclampsia and
intrauterine growth restriction |
|
|
K
Czajkowski, J Sienko, I Kostro, M Grymowicz et al |
Poland |
Lipid profile in pregnancy complicated by chronic
hypertension |
|
|
A Chkheidze, M Zodelava, T Mamaladze et al |
Georgia |
Study of bone mineral density in adolescent
pregnants |
|
|
R Selthofer, T Kulas, R Becarevic et al |
Croatia |
Syndrome Couvelaire |
|
|
|
K
Czajkowski, J Sienko, J Wojcicka, R Smolarczyk et al |
Poland |
Hormonal changes in third trimester of pregnancy
complicated by chronic hypertension |
|
|
D Tutunaru, L Cobac, T Motrenko |
Romania |
Severe preeclampsia and neonatal outcome |
|
|
M
Stanojevic, I Bednas, B Grguric – Koprcina et al |
Croatia |
Early neonatal outcome after delivery in preeclamptic
pregnancies: two year retrospective study |
|
|
K
Czajkowski, J Sienko, J Wojcicka
et al |
Poland |
The correlation between lipid and hormonal
concentrations in the third trimester complicated by PIH |
|
|
D Dedeic,
V Blagaic ml, O Vasilj |
Croatia |
HELLP syndrome with acute renal failure after
preeclampsia: a case report |
|
|
K Czajkowski, I Kostro, J Sienko, M Bros et al |
Poland |
Renal function in third trimester of pregnancy
complicated by chronic hypertension |
|
|
* presenting author bolded |
|
|
|
|
|
Saturday 21st May 2005 |
|
|
|
Name |
Country |
Title |
|
|
Chair: M Carrapato (Portugal),
A Smalcelj (Croatia) |
|
|
A Loganath |
Singapore |
Cytokines and it’s role in uteroplacental
dysfunction |
|
|
M Carapato |
Portugal |
Neonates delivered by preeclamptic mother |
|
|
I Prpic |
Croatia |
Gestosis / preeclampsia - Long term neonatal
outcome |
|
|
A Smalcelj |
Croatia |
Essential hypertension and pregnancy |
|
|
Chair: W Fraser (Canada), H Elkabarity
(Egypt) |
|
|
W Fraser |
Canada |
International trial of antioxidants for the
prevention of preeclampsia |
|
|
H Elkabarity |
Egypt |
Endothelial growth factor, interleuikin-6 and
homocysteine in serum at gestosis |
|
|
M Williams |
USA |
Relationship of maternal leptin, physical activity
and risk of preeclampsia. A prospective study |
|
|
Z Alfirevic |
UK |
Magnesium Sulphate in preeclampsia / eclampsia |
|
|
Chair: R Pepperell (Australia),
R Matijević (Croatia) |
|
|
L Mourachko |
Russia |
SPECIAL LECTURE Pregnancy and delivery management in
women with transplanted kidney |
|
|
R Pepperell |
Australia |
Presentation of 2006 Meeting in
Australia |
|
|
Chair: S Robson (UK), I Prpic
(Croatia) |
|
|
Y Baytur |
Turkey |
The role of classification on the management of
severe preeclampsia |
|
|
TBA |
TBA |
Importance of fetal DNA in prediction of EPH
gestosis |
|
|
S Robson |
UK |
Fluid management in preeclamptic patients |
|
|
R Pepperell |
Australia |
Medico-legal problems in gestosis / preeclampisia -
How we as clinicians can help |
|
|
Chair: A Bolte (The
Netherlands), D Habek (Croatia) |
|
|
A Bolte |
The Netherlands |
Serotonin-2 receptor blockers and preeclampsia |
|
|
D Habek |
Croatia |
Oncotic therapy in management of preeclampsia |
|
|
R Levy |
Israel |
The role of Apoptosis in preeclampsia |
|
|
Chair: A Loganath (Singapore),
D Habek (Croatia), O Vasilj (Croatia) |
|
|
S
Vadachkoria, GB Woelk, K Mahomed et al |
USA/Zimbabwe |
Elevated sVCAM-1, homocyst(e)inemia and
hypertriglyceridemia in relation to preeclampsia risk |
|
|
MI Samardziski, K Stankova,I Ristevska |
Macedonia |
Severe preeclampsia - Influence on prematurity and
intrauterine growth restriction |
|
|
D Tutunaru, R Vladareanu, T Motrenko et al |
Romania |
Supraselective vasodilatator therapy in
preeclampsia |
|
|
K Czajkowski, J Sienko, E Romejko et al |
Poland |
Perinatal outcome in the 3rd trimester complicated by
hypert. in the course of chronic renal disease |
|
|
L Mohorovic |
Croatia |
Can methaemoglobin levels serve to predict
preeclampsia before clinically evident disease? |
|
|
V Sucur, M Luznik, D
Bosilj |
Slovenia |
HELLP syndrome at 21 weeks gestation – Case
Report |
|
|
N Beridze, A Chkheidze, T Pirtsxalava et al |
Georgia |
Post partum examinations by method of electro
puncture diagnostics |
|
|
MI Kovalev, X Clemente |
Russia |
Significance of EPH gestosis in the structure of
indications to operative delivery |
|
|
VA Bourlev, ZS Zaidieva, VL Tioutiounnik |
Russia |
Placental growth factor, early prognostic factor of
placental insufficiency |
|
|
E
Petkovska, S Jancevska, DS Filipce |
Macedonia |
Early neonatal management of the growth restricted
infant |
|
|
XM Clemente, NM Pobedynsky, AI Ishenko |
Russia |
Ozone therapy for placentary insufficiency at EPH
gestosis |
|
|
F Skokic, G Radoja |
Bosnia and Herzegovina |
Haematocrit as a biochemical marker of brain ischemia
in neonates born of mothers with H gestosis |
|
|
J
Teliga-Czajkowska, KM Wiêch, T Maciejewski et al |
Poland |
Acute fatty liver of pregnancy (AFLP), a case
report |
|
|
A Ahmed |
UK |
Anitiangiogenic effect of soluble VEGFR-1 in
placental angiogenesis |
|
|
VI
Kulakov, LE Murashko, AV Murashko, NF Kravchenko |
Russia |
Management of CVI pregnant patients |
|
|
S Dekovic, K Begic, J Dizdarevic |
Bosnia and Herzegovina |
Incidence of gestosis in special conditions of
surrounded Sarajevo during the war |
|
|
* presenting author bolded |
|
|
|
|
Sunday 22nd May 2005 |
|
|
|
Name |
Country |
Title |
|
|
Chair: M Williams (USA), V Latin
(Croatia) |
|
|
V Latin |
Croatia |
EPH gestosis - management in the outpatient clinic:
What can we do |
|
|
M Williams |
USA |
Abnormal lipid profiles in the pathophysiology of
preeclampsia / gestosis |
|
|
S Robson |
UK |
Underlying pathophysiology of preeclampsia - Progress
in the last decades |
|
|
B Anic |
Croatia |
Antiphospholipid syndreome |
|
|
Chair: W Holzgreve (Switzerland), B Anic
(Croatia) |
|
|
W Holzgreve |
Switzerland |
New insights into the pathophysiology of preeclampsia
from fetal nucleic acids in maternal circulation |
|
|
E Rippmann |
Switzerland |
EPH gestosis versus Diastolic Hypertension and
Proteinuria |
|
|
AC Vidaeff |
USA |
The use of corticosteroids in patients with
gestosis |
|
|
O Petrovic |
Croatia |
Fetal maturity in preeclamptic pregnancies |
|
|
Chair: ET Rippmann
(Switzerland), I Dekaris (Croatia) |
|
|
W Fraser |
Canada |
SPECIAL LECTURE Amnioinfusion in the cases of
meconium stained amniotic fluid |
|
|
Chair: R Pepperell (Australia),
O Petrovic (Croatia) |
|
|
I Dekaris |
Croatia |
Importance of the eye examination in patients with
severe forms of pregnancy induced hypertension |
|
|
M Matanic Manestar |
Croatia |
The role of anesthetist in peripartal treatment of
preeclampsia |
|
|
|
Submitted abstracts but no presented |
|
|
|
D Tutunaru, SI Avram, FD Lebit, B Alexandru |
Romania |
The prevalence of anti-2microglobulin i versus ACL
antibodies in APL syndrome |
|
|
K Czajkowski, J Sienko, J Wojcicka, P Milewczyk et al |
Poland |
Renal parameters in the 3rd trimester of pregnancy
complicated by hypertension in CRD |
|
|
K Czajkowski, J Sienko, J Wojcicka, M Grymowicz et al |
Poland |
Lipid metabolism in the 3rd trimester of pregnancy
complicated by hypertension in CRD |
|
|
K Czajkowski, J Sienko, I Kostro, M Bros et al |
Poland |
Hormones in the 3rd trimester of pregnancy
complicated by hypertension in CRD |
|
|
LE Mourachko, IV Toumbaev |
Russia |
Antihypertensive therapy influence on endothelial
dysfunction in gestosis |
|
|
LE Murashko, RA Nurutdinova, GT Sukhikh, LZ Fayzullin |
Russia |
Role of HLA system in gestosis pathogenesis |
|
|
LE Murashko, NF Ravchenko, NI Limenchenko, AV Murashko |
Russia |
Pregnancy and delivery in women with trasplanted
kidney |
|
|
MA
Kulterbayeva, ZT Badoyeva, MS Gubareva et al |
Russia |
Influence of hypertension on gestosis rate and
severity |
|
|
MI Kovalev |
Russia |
EPH
gestosis frequency in modern clinical practice |
|
|
|
|
|
|
|